/

Other

/

Porton Biopharma Ltd

Porton Biopharma Ltd

Porton Biopharma Ltd

Verified Nov 2026

Other

·

United Kingdom flag

Salisbury, England

·

Since 2015

Porton Biopharma Limited is a UK-based biopharmaceutical manufacturer founded in 2015, headquartered in Salisbury, England, with 100-200 employees and estimated revenue of $10-50 million. The company specializes in developing and manufacturing niche therapeutics and vaccines for cancer, infectious diseases, and critical health conditions, serving healthcare providers, military personnel, and government partners globally. The company is the sole manufacturer of Erwinase, an essential treatment for acute lymphoblastic leukaemia, and produces the UK's licensed anthrax vaccine.

Porton Biopharma Ltd

Verified Nov 2026

AT A GLANCE

Founded

2015

Headquarters

United Kingdom flag

Salisbury, England

Employees

100-200

Ownership

Porton Biopharma Ltd at a glance

Revenue

$10-50M

Est. band

Employees

100-200

Founded

2015

Headquarters

Salisbury, England

Industries

Automotive

Electric Vehicles

Medical

Military & Defense

Overview

Porton Biopharma Limited is a UK-based biopharmaceutical manufacturer founded in 2015, headquartered in Salisbury, England, with 100-200 employees and estimated revenue of $10-50 million. The company specializes in developing and manufacturing niche therapeutics and vaccines for cancer, infectious diseases, and critical health conditions, serving healthcare providers, military personnel, and government partners globally. The company is the sole manufacturer of Erwinase, an essential treatment for acute lymphoblastic leukaemia, and produces the UK's licensed anthrax vaccine.

At a glance

Attribute

Detail

Founded

2015

Headquarters

Salisbury, England

Employees

100-200

Revenue

$10-50M (estimated)

What Porton Biopharma Ltd makes

Porton Biopharma develops and manufactures therapeutic proteins, enzymes, and vaccines alongside contract manufacturing services that include process development, analytical development, and fermentation expertise for biological pharmaceuticals.

Latest developments

Company details

The company was spun out from Public Health England in 2015 and operates as a privately held manufacturer serving critical global health markets. Porton Biopharma Ltd was founded in 2015, has an estimated 100-200 employees, and is headquartered in Salisbury, England.

Frequently asked questions

What does Porton Biopharma Ltd do?

Porton Biopharma Limited is a UK-based biopharmaceutical manufacturer founded in 2015, headquartered in Salisbury, England, with 100-200 employees and estimated revenue of $10-50 million. The company specializes in developing and manufacturing niche therapeutics and vaccines for cancer, infectious diseases, and critical health conditions, serving healthcare providers, military personnel, and government partners globally. The company is the sole manufacturer of Erwinase, an essential treatment for acute lymphoblastic leukaemia, and produces the UK's licensed anthrax vaccine.

Where is Porton Biopharma Ltd headquartered?

Porton Biopharma Ltd is headquartered in Salisbury, England (Manor Farm Road, Salisbury, England, SP4 0).

When was Porton Biopharma Ltd founded?

Porton Biopharma Ltd was founded in 2015.

How big is Porton Biopharma Ltd?

Porton Biopharma Ltd has an estimated 100-200 employees, with revenue in the $10-50M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Salisbury, England (HQ)Headquarters · United Kingdom
Salisbury, England (HQ)Manor Farm Road, Salisbury, England, SP4 0, United KingdomHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.